NO146280C - BIS-TETRAHYDROPYRANYLETERS FOR USE AS INTERMEDIATE FOR PREPARING A PHYSIOLOGY ACTIVE P-BIFENYLESTER OF A PROSTAGLANDIN ANALOGUE OF THE E OR F SERIES - Google Patents

BIS-TETRAHYDROPYRANYLETERS FOR USE AS INTERMEDIATE FOR PREPARING A PHYSIOLOGY ACTIVE P-BIFENYLESTER OF A PROSTAGLANDIN ANALOGUE OF THE E OR F SERIES

Info

Publication number
NO146280C
NO146280C NO743588A NO743588A NO146280C NO 146280 C NO146280 C NO 146280C NO 743588 A NO743588 A NO 743588A NO 743588 A NO743588 A NO 743588A NO 146280 C NO146280 C NO 146280C
Authority
NO
Norway
Prior art keywords
tetrahydropyranyleters
bifenylester
bis
preparing
series
Prior art date
Application number
NO743588A
Other languages
Norwegian (no)
Other versions
NO743588L (en
NO146280B (en
Inventor
Michael Ross Johnson
Thomas Ken Schaaf
Jasit Singh Bindra
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Publication of NO743588L publication Critical patent/NO743588L/en
Application filed by Pfizer filed Critical Pfizer
Publication of NO146280B publication Critical patent/NO146280B/en
Publication of NO146280C publication Critical patent/NO146280C/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/54Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/54Quaternary phosphonium compounds
    • C07F9/5407Acyclic saturated phosphonium compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Pyrane Compounds (AREA)
  • Furan Compounds (AREA)
NO743588A 1972-11-08 1974-10-03 BIS-TETRAHYDROPYRANYLETERS FOR USE AS INTERMEDIATE FOR PREPARING A PHYSIOLOGY ACTIVE P-BIFENYLESTER OF A PROSTAGLANDIN ANALOGUE OF THE E OR F SERIES NO146280C (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30481572A 1972-11-08 1972-11-08

Publications (3)

Publication Number Publication Date
NO743588L NO743588L (en) 1974-05-09
NO146280B NO146280B (en) 1982-05-24
NO146280C true NO146280C (en) 1982-09-01

Family

ID=23178143

Family Applications (2)

Application Number Title Priority Date Filing Date
NO4290/73A NO145437C (en) 1972-11-08 1973-11-07 ANALOGY PROCEDURE FOR PREPARING A PHYSIALLY ACTIVE P-BIFENYLESTER OF A PROSTAGLANDIN ANALOGUE OF THE E OR F SERIES
NO743588A NO146280C (en) 1972-11-08 1974-10-03 BIS-TETRAHYDROPYRANYLETERS FOR USE AS INTERMEDIATE FOR PREPARING A PHYSIOLOGY ACTIVE P-BIFENYLESTER OF A PROSTAGLANDIN ANALOGUE OF THE E OR F SERIES

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO4290/73A NO145437C (en) 1972-11-08 1973-11-07 ANALOGY PROCEDURE FOR PREPARING A PHYSIALLY ACTIVE P-BIFENYLESTER OF A PROSTAGLANDIN ANALOGUE OF THE E OR F SERIES

Country Status (24)

Country Link
JP (1) JPS5644068B2 (en)
AR (2) AR204816A1 (en)
AT (1) AT347607B (en)
BE (1) BE807047A (en)
CA (1) CA1027559A (en)
CH (1) CH601222A5 (en)
CS (1) CS188175B2 (en)
DD (2) DD111370A5 (en)
DE (2) DE2365999A1 (en)
ES (2) ES420326A1 (en)
FI (1) FI58116C (en)
FR (2) FR2205339B1 (en)
GB (1) GB1456511A (en)
HU (2) HU171818B (en)
IE (1) IE39686B1 (en)
IL (1) IL43553A (en)
IN (1) IN139905B (en)
NL (1) NL7315240A (en)
NO (2) NO145437C (en)
PH (2) PH15504A (en)
SE (2) SE420198B (en)
SU (2) SU538659A3 (en)
YU (2) YU287973A (en)
ZA (1) ZA738593B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2361410A1 (en) * 1972-07-13 1978-03-10 Pfizer DIALKYL ALKYLPHOSPHONATES, USEFUL AS PROSTAGLANDIN SYNTHESIS INTERMEDIARIES
US3929862A (en) * 1974-01-08 1975-12-30 Upjohn Co Substituted tolylesters of PGF{HD 2{B {60
US3998869A (en) * 1974-11-14 1976-12-21 The Upjohn Company Substituted anilide esters of 16-substituted PGE2
DE2737807A1 (en) * 1976-08-27 1978-03-09 Pfizer C LOW 1 -P-BIPHENYLESTER OF OMEGA-PENTANORPROSTAGLANDINES
US6531504B2 (en) * 2001-05-17 2003-03-11 Allergan, Inc. Prostanoic acid derivatives as agents for lowering intraocular pressure

Also Published As

Publication number Publication date
DE2365999A1 (en) 1977-05-12
ATA937173A (en) 1978-05-15
YU264480A (en) 1983-04-27
GB1456511A (en) 1976-11-24
AR202311A1 (en) 1975-05-30
DE2355042A1 (en) 1974-05-22
IE39686B1 (en) 1978-12-06
PH15504A (en) 1983-02-03
NO145437C (en) 1982-03-24
YU287973A (en) 1982-02-25
NO743588L (en) 1974-05-09
SE7704369L (en) 1977-04-15
FR2275452B1 (en) 1977-12-16
NO146280B (en) 1982-05-24
SU538659A3 (en) 1976-12-05
JPS5644068B2 (en) 1981-10-16
ES420326A1 (en) 1976-03-16
ES434687A1 (en) 1976-12-16
FR2205339B1 (en) 1980-01-04
IL43553A0 (en) 1974-03-14
CH601222A5 (en) 1978-06-30
AT347607B (en) 1979-01-10
ZA738593B (en) 1974-10-30
PH13794A (en) 1980-10-01
DD111370A5 (en) 1975-02-12
FI58116B (en) 1980-08-29
IE39686L (en) 1974-05-08
FR2275452A1 (en) 1976-01-16
AR204816A1 (en) 1976-03-05
SE420198B (en) 1981-09-21
CA1027559A (en) 1978-03-07
CS188175B2 (en) 1979-02-28
SU1021340A3 (en) 1983-05-30
HU171945B (en) 1978-04-28
IL43553A (en) 1979-10-31
BE807047A (en) 1974-05-08
NO145437B (en) 1981-12-14
HU171818B (en) 1978-03-28
FR2205339A1 (en) 1974-05-31
FI58116C (en) 1980-12-10
NL7315240A (en) 1974-05-10
JPS49100060A (en) 1974-09-20
DD113211A5 (en) 1975-05-20
AU6222573A (en) 1975-05-08
IN139905B (en) 1976-08-14

Similar Documents

Publication Publication Date Title
SE418080B (en) CFYCLOPROPANCARBOXYLIC ACID ESTERS FOR USE AS INSECTICIDE
NO141752C (en) Substituted acetic acid esters for use as pesticides
NO139072C (en) PROCEDURE FOR THE PREPARATION OF A PET PET PRODUCT
ATA920873A (en) SINGLE USE PACKAGING
NO143663C (en) ANALOGY PROCEDURE FOR PREPARING A PHYSIOLOGY ACTIVE PROSTAGLAND CONNECTION OF THE E OR F SERIES
SE391520B (en) PROCEDURE FOR THE PREPARATION OF SUBSTITUTED 11-DEOXIPROSTAGLAND INTERVENTIONS OF TYPE PGE
SE400158B (en) USE OF CERTAIN N-PHOSPHONOMETHYL GYLCINS AS HERBICIDES
NO143747C (en) CARBOXYAL COOLESTERS OF N-PHOSPHONE METHYLGYLINE FOR USE AS HERBICIDE AGENTS
SE411748B (en) CYCLEOPROPANCARBOXYLIC ACID ESTERS FOR USE AS PESTICIDES
SE448992B (en) PROCEDURE FOR PREPARING AN OMEGA-PENTANOR PROSTAGLANDIN FROM THE E OR F SERIES
NO144830C (en) SUBSTITUTED CYCLOPENTAND DERIVATIVES FOR USE AS INTERMEDIATE BY PREPARING A PHYSIOLOGY ACTIVE PROSTAGLAND CONNECTION OF THE E OR F SERIES
SE413245B (en) PROCEDURE FOR MANUFACTURING OPTICAL ACTIVE (+) - LAKTON- OR -TOLAKTON SOCIETY
SE396072B (en) USE OF CIS-DIHYDROMETHYL MONATE AS A SCENT
SE407231B (en) USE OF ALKALINE CROSS-BATTERY ACRYLESTER COPYMARIZE AS A STICK
NO146280C (en) BIS-TETRAHYDROPYRANYLETERS FOR USE AS INTERMEDIATE FOR PREPARING A PHYSIOLOGY ACTIVE P-BIFENYLESTER OF A PROSTAGLANDIN ANALOGUE OF THE E OR F SERIES
SE397201B (en) PROCEDURE FOR THE PREPARATION OF GLUCOSISOMERAS FROM A MICRO-ORGANISM OF THE GENEAL ACTIONOPLANES
NO145383C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE SUBSTITUTED INDOLS.
NO143499C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE INHANDER DERIVATIVES
SE405064B (en) USE OF ISOMALTITOL AS A CALORIOUS CLEANER
SE385123B (en) METHODS OF MANUFACTURING RACEMIC OR OPTICALLY ACTIVE 13BETA-ETHYL-17ALFA-ETHYNYL-GON-4-EN-3-ON-17BETA-OL
NO791507L (en) COMPOUNDS OF USE AS INTERMEDIATE PRODUCTS FOR THE MANUFACTURE OF THERAPEUTIC ACTIVITIES 4-AMINOAMPHETAMIN DERIVATIVES
NO141121C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF PHYSIOLOGICALLY ACTIVE MORPHOLINE DERIVATIVES
SE401784B (en) USE OF OMEGA CHLORINE-OMEGA-ISONITROSOACETON PHENON AS A BACTERICIDE
SE402279B (en) CERTAIN STATEMENTS OF 4-CYANOPHENOXYACETONITRILES FOR USE AS FERTILIZERS
AR213387A1 (en) PROCEDURE FOR THE ISOMERIZATION OF GLUCOSE TO LEVULOSE